Dutasteride - JW Pharmaceutical
Alternative Names: Dutasteride tablet formulation - JW Pharmaceutical; J-dartLatest Information Update: 09 Aug 2023
At a glance
- Originator JW Pharmaceutical
- Class Antiandrogens; Antineoplastics; Azasteroids; Eye disorder therapies; Skin disorder therapies; Small molecules
- Mechanism of Action Cholestenone 5 alpha-reductase inhibitors; Testosterone antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Alopecia; Benign prostatic hyperplasia
Most Recent Events
- 09 Aug 2023 Chemical structure information added
- 19 Jul 2023 Launched for Alopecia in Asia (PO) prior to July 2023 (JW Pharmaceutical pipeline, July 2023)
- 18 Jul 2023 Registered for Alopecia in Asia (PO) prior to July 2023 (JW Pharmaceutical pipeline, July 2023)